Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

NAMS

NewAmsterdam Pharma Company NV

May 29 • 04:00PM ET

33.68

-1.74 -4.91 %

Healthcare • Biotechnology • Netherlands • Mid • NASD

Peers: MDGL VKTX RYTM BMRN AXSM KRYS ALNY INCY KROS NBIX

| Held by: CGMM IBB SBIO VHT FYC FFSM ONEQ ESML FHLC DRKY

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-1.80	Insider Own	31.37%	Shs Outstand	116.64M	Perf Week	-5.76%
Market Cap	3.94B	Forward P/E	-	EPS next Y	-1.39	Insider Trans	-4.27%	Shs Float	80.23M	Perf Month	18.47%
Enterprise Value	3.30B	PEG	-	EPS next Q	-0.48	Inst Own	70.96%	Short Float	8.90%	Perf Quarter	-5.02%
Income	-212.73M	P/S	174.45	EPS this Y	-4.95%	Inst Trans	-0.94%	Short Ratio	6.27	Perf Half Y	-16.72%
Sales	22.57M	P/B	5.91	EPS next Y	22.82%	ROA	-27.43%	Short Interest	7.14M	Perf YTD	-3.99%
Book/sh	5.70	P/C	6.18	EPS next 5Y	45.84%	ROE	-29.49%	52W High	42.21 -20.20%	Perf Year	91.04%
Cash/sh	5.45	P/FCF	-	EPS past 3/5Y	-12.98% -	ROIC	-31.98%	52W Low	16.95 98.70%	Perf 3Y	148.19%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-39.71% -	Gross Margin	98.98%	Volatility	5.20% 6.41%	Perf 5Y	247.22%
Dividend TTM	-	EV/Sales	146.21	EPS Y/Y TTM	3.91%	Oper. Margin	-953.59%	ATR (14)	2.04	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	9.76	Sales Y/Y TTM	-52.13%	Profit Margin	-942.76%	RSI (14)	47.23	Recom	1.12
Dividend Gr. 3/5Y	- -	Current Ratio	9.76	EPS Q/Q	-16.92%	SMA20	-3.47%	Beta	0.09	Target Price	51.21
Payout	-	Debt/Eq	0.00	Sales Q/Q	2.08%	SMA50	1.65%	Rel Volume	2.16	Prev Close	35.42
Employees	100	LT Debt/Eq	0.00	Earnings	May 07 BMO	SMA200	2.51%	Avg Volume	1.14M	Price	33.68
IPO	Feb 08, 2021	Option/Short	Yes / Yes	EPS/Sales Surpr.	13.38% 72.87%	Trades		Volume	2,459,889	Change	-4.91%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)